2192 — Medlive Technology Co Income Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMid CapHigh Flyer

Annual income statement for Medlive Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	214	284	314	412	558
Cost of Revenue
Gross Profit	156	201	213	251	327
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	108	214	178	159	217
Operating Profit	105	70.5	136	253	341
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	105	69.9	135	253	340
Provision for Income Taxes
Net Income After Taxes	85.2	45.2	126	252	330
Minority Interest
Net Income Before Extraordinary Items
Net Income	85.2	40.6	117	242	315
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	85.2	40.6	117	242	315
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.122	0.093	0.158	0.33	0.428
Dividends per Share